Presence of SARS-CoV-2 Antibodies in Spent Peritoneal Dialysate
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:32 |
|---|---|
| Enthalten in: |
Journal of the American Society of Nephrology : JASN - 32(2021), 8 vom: 04. Aug., Seite 1865-1867 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Wang, Xiaoling [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 05.08.2021 Date Revised 03.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1681/ASN.2021020161 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM327764120 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM327764120 | ||
| 003 | DE-627 | ||
| 005 | 20240403232446.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1681/ASN.2021020161 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1362.xml |
| 035 | |a (DE-627)NLM327764120 | ||
| 035 | |a (NLM)34230102 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Wang, Xiaoling |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Presence of SARS-CoV-2 Antibodies in Spent Peritoneal Dialysate |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 05.08.2021 | ||
| 500 | |a Date Revised 03.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a antibody | |
| 650 | 4 | |a peritoneal dialysis | |
| 650 | 7 | |a Antibodies, Viral |2 NLM | |
| 650 | 7 | |a Coronavirus Nucleocapsid Proteins |2 NLM | |
| 650 | 7 | |a Dialysis Solutions |2 NLM | |
| 650 | 7 | |a Immunoglobulin G |2 NLM | |
| 650 | 7 | |a Phosphoproteins |2 NLM | |
| 650 | 7 | |a Spike Glycoprotein, Coronavirus |2 NLM | |
| 650 | 7 | |a nucleocapsid phosphoprotein, SARS-CoV-2 |2 NLM | |
| 650 | 7 | |a spike protein, SARS-CoV-2 |2 NLM | |
| 700 | 1 | |a Grobe, Nadja |e verfasserin |4 aut | |
| 700 | 1 | |a Patel, Amrish |e verfasserin |4 aut | |
| 700 | 1 | |a Sharma, Shuchita |e verfasserin |4 aut | |
| 700 | 1 | |a Uribarri, Jaime |e verfasserin |4 aut | |
| 700 | 1 | |a Kotanko, Peter |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of the American Society of Nephrology : JASN |d 1990 |g 32(2021), 8 vom: 04. Aug., Seite 1865-1867 |w (DE-627)NLM012606502 |x 1533-3450 |7 nnns |
| 773 | 1 | 8 | |g volume:32 |g year:2021 |g number:8 |g day:04 |g month:08 |g pages:1865-1867 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1681/ASN.2021020161 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 32 |j 2021 |e 8 |b 04 |c 08 |h 1865-1867 | ||